INDICATION

EVENITY™ is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Read More

available osteoporosis therapy. The anabolic effect of EVENITY™ wanes after 12 monthly doses of therapy. Therefore, the duration of EVENITY™ use should be limited to 12 monthly doses. If osteoporosis therapy remains warranted, continued therapy with an antiresorptive agent should be considered. Close

Which patients could benefit from EVENITY™?

Betsey

Fractured while on a bisphosphonate

Postmenopausal Osteoporosis History:

Hypothetical patient

SEE BETSEY'S FULL STORY

An osteoporotic fracture in a postmenopausal woman is an indicator that her bones have deteriorated

After a fracture, many women like Betsey are concerned about suffering from another

Lifestyle:

  • At age 71, Betsey recently lost her husband and currently lives alone
  • She takes care of her 4-year-old twin grandchildren while their parents work, and she loves traveling
  • Betsey is worried what an additional fracture could mean
  • Her doctor wants to prescribe a bone builder

Betsey's first fracture was soon followed by another, and she now needs a bone-building treatment that can decrease her risk of another fracture.

Having a second fracture while being treated for osteoporosis can be confusing and frightening. This is a good time to talk with patients like Betsey about the possibility of transitioning to a bone-building treatment.

Nancy

Active and treatment naïve

Postmenopausal Osteoporosis History:

Hypothetical patient

LEARN MORE ABOUT NANCY

When osteoporosis leads to a fracture, it's a signal that another fracture may soon follow1

Another fracture can impact patients like Nancy

Lifestyle:

  • Nancy is 65 years old, recently retired from teaching, and is on Medicare
  • She and her husband enjoy hiking now that they both are retired
  • But Nancy has been in constant pain from the undiagnosed fracture
  • When she visited her family practitioner, Nancy was shocked to learn the pain was from a vertebral fracture
  • She worries that another fracture could limit their future hiking adventures

Since Nancy is at the highest risk for fracture in the year after her first one, she is looking for a treatment that will rapidly build strong new bone within 12 months.

Patients like Nancy don't always know their pain could be connected to a fracture. It's important to discuss with postmenopausal osteoporosis patients their risk of fracture and treatment options.

IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY INFORMATION

POTENTIAL RISK OF MYOCARDIAL INFARCTION, STROKE, AND CARDIOVASCULAR DEATH
EVENITY™ may increase the risk of myocardial infarction, stroke and cardiovascular death. EVENITY™ should not be initiated in patients who have had a myocardial infarction or stroke within the preceding year. Consider whether the benefits outweigh the risks in patients with other cardiovascular risk factors. Monitor for signs and symptoms of myocardial infarction and stroke and instruct patients to seek prompt medical attention if symptoms occur. If a patient experiences a myocardial infarction or stroke during therapy, EVENITY™ should be discontinued.

References: 1. van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis. 2009;68:99-102.